Tumor necrosis factor (TNF) protects resistant C57BL/6 mice against herpes simplex virus-induced encephalitis independently of signaling via TNF receptor 1 or 2.
about
Tumor Necrosis Factor Alpha Protects against Lethal West Nile Virus Infection by Promoting Trafficking of Mononuclear Leukocytes into the Central Nervous SystemProgress toward in vivo use of siRNAs-IIRift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse modelHerpes simplex virus encephalitis during treatment with etanercept.Transcriptomic analysis of the dialogue between Pseudorabies virus and porcine epithelial cells during infectionChitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model.Interferon regulatory factor 3-dependent pathways are critical for control of herpes simplex virus type 1 central nervous system infection.A single-amino-acid substitution in herpes simplex virus 1 envelope glycoprotein B at a site required for binding to the paired immunoglobulin-like type 2 receptor alpha (PILRalpha) abrogates PILRalpha-dependent viral entry and reduces pathogenesisAbsence of CCR5 increases neutrophil recruitment in severe herpetic encephalitis.Tumor necrosis factor alpha and interleukin-6 facilitate corneal lymphangiogenesis in response to herpes simplex virus 1 infection.Glucocorticoid treatment of MCMV infected newborn mice attenuates CNS inflammation and limits deficits in cerebellar development.Novel antiviral activity of mung bean sprouts against respiratory syncytial virus and herpes simplex virus -1: an in vitro study on virally infected Vero and MRC-5 cell lines.Protection against TNFα-dependent liver toxicity by intraperitoneal liposome delivered DsiRNA targeting TNFα in vivoEffects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccinesInhibition of HSV-1 by chemoattracted neutrophils: supernatants of corneal epithelial cells (HCE) and macrophages (THP-1) treated with virus components chemoattract neutrophils (PMN), and supernatants of PMN treated with these conditioned media inhiConcordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targetsEpstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral ReplicationNonviral delivery of small interfering RNA into pancreas-associated immune cells prevents autoimmune diabetes.The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor MicroenvironmentMicroglia and a functional type I IFN pathway are required to counter HSV-1-driven brain lateral ventricle enlargement and encephalitisThe immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis.Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cordsHerpes simplex virus type 2-induced mortality following genital infection is blocked by anti-tumor necrosis factor alpha antibody in CXCL10-deficient mice.Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitisTNFR2 expression on non-bone marrow-derived cells is crucial for lipopolysaccharide-induced septic shock and downregulation of soluble TNFR2 level in serum.Manipulation of apoptosis and necroptosis signaling by herpesvirusesEnhanced viral clearance and reduced leukocyte infiltration in experimental herpes encephalitis after intranasal infection of CXCR3-deficient mice.Signal transducer and activator of transcription 3 (Stat3) regulates host defense and protects mice against herpes simplex virus-1 (HSV-1) infection.The ribonucleotide reductase R1 subunits of herpes simplex virus types 1 and 2 protect cells against TNFα- and FasL-induced apoptosis by interacting with caspase-8.Tumor Necrosis Factor Alpha-Induced Recruitment of Inflammatory Mononuclear Cells Leads to Inflammation and Altered Brain Development in Murine Cytomegalovirus-Infected Newborn Mice.Targeted delivery of siRNA to macrophages for anti-inflammatory treatment.Herpes simplex virus suppresses necroptosis in human cells.Disruption of TNF-α/TNFR1 function in resident skin cells impairs host immune response against cutaneous vaccinia virus infectionEtanercept reduces neuroinflammation and lethality in mouse model of Japanese encephalitis.Tumor Necrosis Factor-Mediated Survival of CD169+ Cells Promotes Immune Activation during Vesicular Stomatitis Virus Infection.Herpes Encephalitis: A Mortal Complication in a Patient Treated with Immunosuppressive Drugs because of Immune-Related Adverse Events after Ipilimumab Treatment.Insights into the pathogenesis of herpes simplex encephalitis from mouse models
P2860
Q27486917-D772765B-3918-4E97-8E1F-D5C8DCF41574Q28255877-C67B806D-E908-41DD-AB1C-B6F4E23FA84FQ28539632-F4591605-165F-4D1E-AEFF-9E0A4C143297Q30694936-5A49D184-08FD-4518-99DD-6169EB7D636AQ33323240-A5A6DDAC-B405-4F68-BFFE-7A723136E09FQ33712966-F18A5BA7-F097-4A71-890C-1E873846500AQ34120729-529E5BC9-3775-4F9F-AEC1-39E8DDBAD61AQ34178357-B3C21CE9-B984-4E14-AD0F-47F9CBC698C8Q34580437-34FEA138-94D6-464F-9697-9A1B34C0096EQ34594843-14DB8FBF-906F-490E-9D68-2AD620685F32Q34625357-42870824-400B-4A1D-8A79-431AE1CF56F0Q35660366-3EEE1468-47CB-434C-B38C-72F0E60E4DB5Q35875509-27B5F773-54B5-4795-8693-4CE2454D0E1CQ36026319-A75A8DFC-FC3E-4F09-8EF5-827EECBFA4FAQ36063082-DE91BFA2-CB11-4BBA-B50A-56E70232B4A0Q36158922-DE365E4C-19B6-44AC-BCC8-EA455CA44819Q36434290-180AA860-B061-4270-88A6-D83673926B8DQ36460478-ABBB4B90-6F9C-4732-BC20-87831BBB5674Q36658280-8681A99F-9F80-44F6-AE8C-9A6A2F008D1BQ36673928-9A1F11C1-691E-4F54-8065-FB7C9C6134DFQ36747754-E470500E-F28A-4A7D-A67B-96379ED9C675Q36898906-96348FC9-4F99-43AA-B7A4-BB05A56628A4Q36933918-A7F9C448-97C3-4FBC-A66A-D30113FD08DFQ37037960-943895BE-0E68-468B-87DC-4BF55810C322Q37729533-0DBCCE88-FB6E-4597-9B41-FAF2D8C56108Q38398301-F6904494-1A68-4A0F-BFB7-7EC97C965D48Q39002888-F5398B81-D51F-409F-956B-7C45D4075D59Q39103869-F474827D-DDCF-48D7-AB66-73A8885B476AQ39627613-6CC231EE-8609-4999-BCAE-34A6D5C7BDB7Q40358106-6142FA7A-640D-4878-A2F1-5BDCE794A9B6Q41312221-87A775D8-36E0-4C1C-ABCE-1AC2E668F74BQ41487815-8D2CB8DF-C181-4EA2-8AE9-CB219E242F2AQ42115218-49A66CC3-D2F5-49A6-A582-EFDE2175811AQ42230003-EEE093C6-652D-415B-935A-39B68A83DF6DQ45324796-DB1FBCC5-9733-4823-B9A9-DA3531C6613BQ50073542-B0C26BAB-6287-4617-9E29-B844885415CCQ58711258-449A8E26-554E-48BA-BB84-B5FC01C755C9
P2860
Tumor necrosis factor (TNF) protects resistant C57BL/6 mice against herpes simplex virus-induced encephalitis independently of signaling via TNF receptor 1 or 2.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Tumor necrosis factor (TNF) pr ...... aling via TNF receptor 1 or 2.
@en
type
label
Tumor necrosis factor (TNF) pr ...... aling via TNF receptor 1 or 2.
@en
prefLabel
Tumor necrosis factor (TNF) pr ...... aling via TNF receptor 1 or 2.
@en
P2093
P2860
P356
P1433
P1476
Tumor necrosis factor (TNF) pr ...... aling via TNF receptor 1 or 2.
@en
P2093
Carl K Edwards
Edouard Cantin
Patric Lundberg
Paula V Welander
P2860
P304
P356
10.1128/JVI.02243-06
P407
P577
2006-11-15T00:00:00Z